News Search Results
May 19, 2024, 20:14 ET Innovent Announces Oral Presentations at ESMO Plenary and ESMO GI Congress on Clinical Data of IBI363 (PD-1/IL-2) and IBI343 (CLDN18.2 ADC)
that develops, manufactures and commercializes high quality medicines for the treatment of oncology, cardiovascular and metabolic, autoimmune, ophthalmology and other major diseases, announces that the company will deliver oral presentations on clinical data of its first-in-class PD-1/IL-2 bispecific
More news about: Innovent Biologics
May 18, 2024, 07:00 ET Mallinckrodt Presents Data on TERLIVAZ® (terlipressin) for Injection in Patients with Hepatorenal Syndrome (HRS) at the 2024 Digestive Disease Week® (DDW)
segment's areas of focus include autoimmune and rare diseases in specialty areas like neurology, rheumatology, hepatology, nephrology, pulmonology, ophthalmology, and oncology; immunotherapy and neonatal respiratory critical care therapies; analgesics; and gastrointestinal products. Its Specialty Generics
More news about: Mallinckrodt plc
May 16, 2024, 08:00 ET InMode to Present at Jefferies Healthcare Conference
technologies to offer a comprehensive line of products across several categories for plastic surgery, gynecology, dermatology, otolaryngology, and ophthalmology. For more information about InMode and its wide array of medical technologies, visit www.inmodemd.com.
More news about: InMode LTD
May 15, 2024, 16:01 ET Kodiak Sciences Announces Recent Business Highlights and First Quarter 2024 Financial Results
presentations: We presented a breadth of data on our early- and late-phase retina pipeline at the Association for Research in Vision and Ophthalmology ("ARVO") 2024 Annual Meeting. Our presentations included clinical and non-clinical data on our ABC Platform investigational medicines tarcocimab
More news about: Kodiak Sciences Inc.
May 15, 2024, 13:50 ET The Adoption of Multimodal Imaging Market to Boom, Integration of PET/CT Technology to Reshape the Future of the Market - Arizton
PET/CTPET/MRSPECT/CTOCT/FMTOthersApplication Diagnostic & ClinicalBrain & NeurologyOncologyCardiologyOphthalmologyOthersResearchEnd-user HospitalsDiagnostic Imaging CentersAcademic
More news about: Arizton Advisory & Intelligence
May 14, 2024, 22:36 ET Drug Discovery Outsourcing Market size is set to grow by USD 1.79 bn from 2024-2028, robust demand for biosimilars to boost the market growth, Technavio
multiple sclerosis, tuberculosis, and various target identification and screening methods for the respiratory system, pain and anesthesia, oncology, ophthalmology, hematology, endocrine, gastrointestinal, immunomodulation, anti-infective, cardiovascular, central nervous system, dermatology, genitourinary system,
More news about: Technavio
May 14, 2024, 14:46 ET Proposed Bipartisan Legislation Would Create First Federally Funded Program to Address Children's Vision and Eye Health
A broad spectrum of public health organizations support the legislation, including American Academy of Ophthalmology, American Academy of Optometry, American Association for Pediatric Ophthalmology and Strabismus, American Optometric Association, American Society of Ophthalmic Registered Nurses, Association
More news about: Prevent Blindness
May 14, 2024, 08:00 ET Two Constitution Surgery Alliance Facilities are Named in U.S. News & World Report's Inaugural "Best Ambulatory Surgery Centers" Edition
East Bay, an AAAHC-accredited facility in Swansea, Massachusetts, was named in the Best Ophthalmology category. Middlesex, an AAAHC-accredited facility in Middletown, Connecticut,
More news about: Constitution Surgery Alliance
May 14, 2024, 00:01 ET U.S. News & World Report Announces Inaugural Ratings of Best Ambulatory Surgery Centers
CareJourney – rated nearly 5,000 surgery centers in four separate specialty areas: Colonoscopy & Endoscopy, Ophthalmology, Orthopedics & Spine, and Urology. Ambulatory surgery centers were
More news about: U.S. News & World Report, L.P.
May 13, 2024, 10:15 ET Does Your Dog Need Glasses? From Removing Cataracts and Performing Surgeries to Restore Vision, Veterinarians and Veterinary Nurses/Technicians Master Ophthalmology and Other New Skills at the 23rd NAVC Institute
and hands-on experience in ophthalmology over four days of immersive hands-on training with world-renowned veterinary ophthalmologists. The unique program enables veterinary professionals to master new skills they can immediately put into practice. In addition to ophthalmology, NAVC Institute provides in-depth
More news about: North American Veterinary Community
May 10, 2024, 13:51 ET Piramal Pharma Limited Announces Results for Q4 and FY2024
(formerly Allergan India Pvt Ltd), a joint venture between Allergan (now part of AbbVie) and PPL, has emerged as one of the market leaders in the ophthalmology therapy area. Further, PPL has a minority investment in Yapan Bio Private Limited. In October 2020, PPL received a 20% strategic growth investment from the Carlyle Group.
More news about: Piramal Pharma Ltd
May 10, 2024, 13:45 ET Piramal Pharma Limited Announces Results for Q4 and FY2024
(formerly Allergan India Pvt Ltd), a joint venture between Allergan (now part of AbbVie) and PPL, has emerged as one of the market leaders in the ophthalmology therapy area. Further, PPL has a minority investment in Yapan Bio Private Limited. In October 2020, PPL received a 20% strategic growth investment from the Carlyle Group.
More news about: Piramal Pharma Ltd
May 10, 2024, 06:00 ET Capsida Biotherapeutics to Present Preclinical Data for Parkinson's Disease Associated with GBA Mutations Showing High Levels of GCase Enzyme Supplementation Following IV Administration
programs, the Company has validating CNS partnerships with AbbVie, Lilly, CRISPR Therapeutics, and the AbbVie partnership was expanded to include ophthalmology disorders. Capsida was founded in 2019 by lead investors Versant Ventures and Westlake Village BioPartners and originated from groundbreaking research
More news about: Capsida Biotherapeutics
May 09, 2024, 07:01 ET World's Most Influential People in Ophthalmology
Kathleen and Stanley J. Glaser Chair in Ophthalmology, was also named to the Ophthalmologist Power Lists 2014, 2016, 2018, 2022, and 2023. Holder of the John T. Flynn Chair in Ophthalmology, Hilda Capó, M.D., specializes in pediatric ophthalmology and adult strabismus. She is world-renowned
More news about: UNIVERSITY OF MIAMI - OTHER SCHOOLS
May 09, 2024, 06:45 ET Mallinckrodt plc Reports First Quarter 2024 Financial Results and Reaffirms Full Year Guidance
segment's areas of focus include autoimmune and rare diseases in specialty areas like neurology, rheumatology, hepatology, nephrology, pulmonology, ophthalmology and oncology; immunotherapy and neonatal respiratory critical care therapies; analgesics; and gastrointestinal products. Its Specialty Generics
More news about: Mallinckrodt plc
May 09, 2024, 03:00 ET Formosa Pharmaceuticals Announces Licensing Agreement with Tabuk Pharmaceuticals, for Commercialization of Clobetasol Propionate Ophthalmic Suspension for the Treatment of Inflammation and Pain Following Ocular Surgery
Pharmaceuticals, Inc. Formosa Pharmaceuticals, Inc. (6838.TWO) is a clinical stage biotechnology company with primary focus in the areas of ophthalmology and oncology. The company's proprietary nanoparticle formulation technology (APNT™), through which APP13007 was developed, improves the dissolution
More news about: Formosa Pharmaceuticals Inc.
May 08, 2024, 20:00 ET Head-to-head Superiority to High-dose Dulaglutide: Innovent's First Phase 3 Clinical Trial of Mazdutide in Chinese Patients with Type 2 Diabetes Met Study Endpoints
that develops, manufactures and commercializes high-quality medicines for the treatment of oncology, autoimmune, cardiovascular and metabolic, ophthalmology and other major diseases, announces that the Phase 3 clinical trial (DREAMS-2) of mazdutide (Innovent R&D code: IBI362), a glucagon-like peptide-1
More news about: Innovent Biologics
May 08, 2024, 17:30 ET Kyowa Kirin Will Present Pre-Clinical Data at the Association for Research in Vision and Ophthalmology Annual Meeting 2024
ocular tissue distribution after ocular instillation of tivozanib eye drops will be presented at the upcoming Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting to be held in Seattle, Washington from May 5-9, 2024.
More news about: Kyowa Kirin
May 08, 2024, 08:03 ET InMode Announces P1 Offshore Racing Partnership with Female Driver Victoria Rand
technologies to offer a comprehensive line of products across several categories for plastic surgery, gynecology, dermatology, otolaryngology, and ophthalmology. For more information about InMode and its wide array of medical technologies, visit www.inmodemd.com.
More news about: InMode Ltd.
May 07, 2024, 16:00 ET Santa J. Ono, University of Michigan President, Joins USJF Board
drew widespread recognition for his groundbreaking research on ophthalmology and immunology, in particular for his work on macular degeneration and deteriorating eyesight. In addition to his presidential duties, Ono is professor of ophthalmology and visual sciences, and microbiology and immunology, at
More news about: United States-Japan Foundation
May 07, 2024, 12:15 ET Modern Vision Centers: Redefining the Patient Eye Care Experience Through a Fusion of Expertise, Technology, and Personalized Solutions
May 7, 2024 /PRNewswire/ -- Modern Vision Centers (MVC), a revolutionary network of premier optometry, medical ophthalmology, and refractive surgery practices, proudly announces its official debut, offering comprehensive and personalized eye care solutions that set a new
More news about: Modern Vision Centers
May 07, 2024, 08:38 ET Turn Biotechnologies Discussed Emerging Therapies at Aesthetic Plastic Surgery Society Meeting
company is completing pre-clinical research on tailored therapies targeting indications in dermatology and immunology, and developing therapies for ophthalmology, osteo-arthritis, and the muscular system. For more information, see
More news about: Turn Biotechnologies
May 07, 2024, 08:33 ET Clear Eyesight Takes Huge Leap Forward with New Odyssey "Permanent Vision Correction Lens"
the United States, having performed over 80,000 eye surgeries. AGEI is nationally recognized for its pioneering advances in ophthalmology, compassionate, patient-centric care, and a dedication to supporting its patients and the community's health and well-being. Contact information:
More news about: Assil Gaur Eye Institute of Los Angeles
May 07, 2024, 07:00 ET Nanoscope Therapeutics Announces Presentations in Upcoming ASGCT Annual Meeting and Retina World Congress
in patients with inherited retinal degenerations (IRDs). This will be followed by a panel discussion moderated by Peter Kaiser, MD, Professor of Ophthalmology at Cole Eye Institute in Cleveland Clinic Lerner College of Medicine. Presentation Title: Longitudinal BCVA and Safety Analysis of
More news about: Nanoscope Therapeutics
May 07, 2024, 06:00 ET Capsida Biotherapeutics Presents New Preclinical Evidence Indicating Novel First-in-Class IV-Administered Gene Therapy Effectively Treats Genetic Epilepsy Due to STXBP1 Mutations
partnerships with AbbVie, Lilly, CRISPR Therapeutics, and the AbbVie partnership was expanded to include ophthalmology disorders. Capsida was founded in 2019 by lead investors Versant Ventures and Westlake Village BioPartners
More news about: Capsida Biotherapeutics